Entourage Health Corp
Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary's … Read more
Entourage Health Corp (ETRGF) - Net Assets
Latest net assets as of September 2024: $-172.21 Million USD
Based on the latest financial reports, Entourage Health Corp (ETRGF) has net assets worth $-172.21 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($24.68 Million) and total liabilities ($196.89 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-172.21 Million |
| % of Total Assets | -697.81% |
| Annual Growth Rate | N/A |
| 5-Year Change | -208.26% |
| 10-Year Change | N/A |
| Growth Volatility | 1342.86 |
Entourage Health Corp - Net Assets Trend (2014–2023)
This chart illustrates how Entourage Health Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Entourage Health Corp (2014–2023)
The table below shows the annual net assets of Entourage Health Corp from 2014 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-147.29 Million | -45.49% |
| 2022-12-31 | $-101.24 Million | -572.50% |
| 2021-12-31 | $21.43 Million | -71.08% |
| 2020-12-31 | $74.09 Million | -45.55% |
| 2019-12-31 | $136.06 Million | +76.49% |
| 2018-12-31 | $77.09 Million | +206.74% |
| 2017-12-31 | $25.13 Million | +3950.02% |
| 2016-12-31 | $620.55K | -6.56% |
| 2015-12-31 | $664.14K | -4.70% |
| 2014-12-31 | $696.92K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Entourage Health Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 36540521100.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $186.23 Million | % |
| Other Components | $32.02 Million | % |
| Total Equity | $-147.29 Million | 100.00% |
Entourage Health Corp Competitors by Market Cap
The table below lists competitors of Entourage Health Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
TCW Transform Systems ETF
NASDAQ:PWRD
|
$920.01K |
|
Enry S Island Spa Sb
VI:EIOS
|
$920.38K |
|
Sino AG
XETRA:XTP
|
$921.71K |
|
Insight Acquisition Corp. Class A Common Stock
NASDAQ:INAQ
|
$921.81K |
|
PT Multisarana Intan Eduka Tbk
JK:MSIE
|
$919.37K |
|
Directa Plus Plc
PINK:DTPKF
|
$917.75K |
|
Leader Capital Holdings Corp
PINK:LCHD
|
$917.51K |
|
Maxcom SA
WAR:MXC
|
$917.36K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Entourage Health Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -101,238,935 to -147,294,652, a change of -46,055,717.
- Net loss of 46,168,010 reduced equity.
- Other comprehensive income decreased equity by 8,945,738.
- Other factors increased equity by 9,058,031.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-46.17 Million | -31.34% |
| Other Comprehensive Income | $-8.95 Million | -6.07% |
| Other Changes | $9.06 Million | +6.15% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Entourage Health Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $0.38 | $0.00 | x |
| 2015-12-31 | $0.65 | $0.00 | x |
| 2016-12-31 | $0.60 | $0.00 | x |
| 2017-12-31 | $0.44 | $0.00 | x |
| 2018-12-31 | $0.72 | $0.00 | x |
| 2019-12-31 | $1.17 | $0.00 | x |
| 2020-12-31 | $0.36 | $0.00 | x |
| 2021-12-31 | $0.09 | $0.00 | x |
| 2022-12-31 | $-0.33 | $0.00 | x |
| 2023-12-31 | $-0.48 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Entourage Health Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -113.40%
- • Asset Turnover: 1.30x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-66.50%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | -18.77% | 0.00% | 0.00x | 1.01x | $-200.51K |
| 2015 | -4.94% | 0.00% | 0.00x | 1.02x | $-99.19K |
| 2016 | -15.86% | -27.86% | 0.55x | 1.04x | $-160.46K |
| 2017 | -35.04% | -606.81% | 0.04x | 1.58x | $-11.32 Million |
| 2018 | -1.16% | -11.25% | 0.09x | 1.14x | $-8.60 Million |
| 2019 | -8.45% | -55.19% | 0.10x | 1.54x | $-25.10 Million |
| 2020 | -134.29% | -338.02% | 0.17x | 2.31x | $-106.90 Million |
| 2021 | -446.51% | -226.32% | 0.29x | 6.73x | $-97.81 Million |
| 2022 | 0.00% | -432.51% | 0.88x | 0.00x | $-166.74 Million |
| 2023 | 0.00% | -113.40% | 1.30x | 0.00x | $-31.44 Million |
Industry Comparison
This section compares Entourage Health Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Entourage Health Corp (ETRGF) | $-172.21 Million | -18.77% | N/A | $919.99K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |